NEW YORK (GenomeWeb News) – Investigators in the UK and the Netherlands have partnered to use genome sequencing to uncover genomic and biochemical characteristics of four human cancers and to screen drug combinations aimed at creating personalized treatments.

The researchers at the Wellcome Trust Sanger Institute and the Netherlands Cancer Institute, or NKI, have been awarded a £14.5 million ($18.9 million) Synergy grant from the European Research Council to fund the effort, which is part of the ERC's CombatCancer initiative, the European Commission said yesterday.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: variant linked to canine cleft lip, new compression tool, and more.

GNC will start using DNA testing to authentic the presence of plants included in its labels, following an agreement with the New York Attorney General.

Fareed Zakaria writes that instead of focusing solely on STEM-related courses, students would do well to pursue the liberal arts if they want to be technology innovators.

A Harvard Business Review study found four major patterns of gender biases and added that black and Latina scientists further had to navigate racial stereotypes.